Diagnostic and prognostic significance of CDKN2A/CDKN2B deletions in patients with transformed mycosis fungoides and primary cutaneous CD30‐positive lymphoproliferative disease. (26th January 2015) - Nicolae‐Cristea, A.R.; Benner, M.F.; Zoutman, W.H.; van Eijk, R.; Jansen, P.M.; Tensen, C.P.; Willemze, R.